These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 5717707)

  • 21. [Studies on pulmonary function in progressive muscular dystrophy. (1)].
    Saeki B; Fukuyama K; Miyoshi M; Tani J; Koshiyama K
    Iryo; 1967 Jul; 21(7):794-9. PubMed ID: 5582474
    [No Abstract]   [Full Text] [Related]  

  • 22. Intellectual function in Duchenne muscular dystrophy: the influence of penicillamine.
    Buchanan DC; Roelofs RI; White DK; Saavedra de Arango G
    Arch Phys Med Rehabil; 1981 Dec; 62(12):623-5. PubMed ID: 7032457
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Single-fiber EMG in muscular dystrophy].
    Claes G; De Meirsman J
    Acta Belg Med Phys; 1985; 8(1):27-34. PubMed ID: 3160195
    [No Abstract]   [Full Text] [Related]  

  • 24. [Masticatory function in patients with progressive muscular dystrophy].
    Kobayashi M
    Hiroshima Daigaku Shigaku Zasshi; 1982; 14(1):42-56. PubMed ID: 6958750
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term electrocardiographic studies in patients with Duchenne progressive muscular dystrophy.
    Lukasik E; Liszewska-Pfejfer D; Rubach K; Szwed H
    Acta Med Pol; 1980; 21(2):181-91. PubMed ID: 7211467
    [No Abstract]   [Full Text] [Related]  

  • 26. Manual muscle testing.
    Mendell JR; Florence J
    Muscle Nerve; 1990; 13 Suppl():S16-20. PubMed ID: 2233877
    [No Abstract]   [Full Text] [Related]  

  • 27. [Function of the adrenal gland in progressive muscular dystrophy].
    Abe M; Nakahara T; Annaka S; Kanno M
    Iryo; 1969 Oct; 23(10):1298-305. PubMed ID: 5364981
    [No Abstract]   [Full Text] [Related]  

  • 28. [Sympathetic mediator theory of the pathogenesis of progressive muscular dystrophies (a review)].
    Badalian LO; Temin PA; Dzhabarov BD; Il'in IL; Kovaleva MIu
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1981; 81(11):1722-6. PubMed ID: 6119861
    [No Abstract]   [Full Text] [Related]  

  • 29. Motor unit changes in inflammatory myopathy and progressive muscular dystrophy.
    Rowińska-Marcińska K; Szmidt-Sałkowska E; Kopeć A; Wawro A; Karwańska A
    Electromyogr Clin Neurophysiol; 2000; 40(7):431-9. PubMed ID: 11142114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Macroemg in manifesting carriers of Duchenne muscular dystrophy.
    Szmidt-Sałkowska E; Rowiñska-Marciñska K; Fidziañska A; Hausmanowa-Petrusewicz I
    Electromyogr Clin Neurophysiol; 1999 Mar; 39(2):87-92. PubMed ID: 10207677
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Association between dystrophin and neuronal nitric oxide synthase in muscles of progressive muscular dystrophy].
    Wang S; Shen D
    Zhonghua Yi Xue Za Zhi; 2002 Feb; 82(3):155-7. PubMed ID: 11953148
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Pulmonary function in progressive muscular dystrophy. Follow-up study for 3 years (author's transl)].
    Sato K; Shima K; Ando M; Fukuda Y; Ideta T
    Nihon Naika Gakkai Zasshi; 1975 May; 64(5):483-90. PubMed ID: 1171927
    [No Abstract]   [Full Text] [Related]  

  • 33. [The circulatory system in children suffering from progressive muscular dystrophy].
    Skierska A; Rokicki W
    Wiad Lek; 2001; 54(3-4):208-14. PubMed ID: 11436688
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Intelligence scale and the electroencephalogram in progressive muscular dystrophy].
    Tomonaga M; Muro T; Kito S
    Iryo; 1967 Jul; 21(7):800-6. PubMed ID: 5582475
    [No Abstract]   [Full Text] [Related]  

  • 35. [Value of the test with Nakom for assessing the state of the sympathoadrenal system in patients with different forms of progressive muscular dystrophy].
    Badalian LO; Amanova ZN; Temin PA
    Lab Delo; 1984; (11):649-52. PubMed ID: 6084734
    [No Abstract]   [Full Text] [Related]  

  • 36. [Electrocardiographic findings in the Duchenne-type of progressive muscular dystrophy].
    Nakagawa K; Okamoto S; Goto H; Kato T; Yamamoto K
    Iryo; 1968 Dec; 22(12):1425-38. PubMed ID: 5717711
    [No Abstract]   [Full Text] [Related]  

  • 37. Systolic time intervals in patients with progressive muscular dystrophy treated with sodium selenite and vitamin E.
    Airenne AL; Westermarck T
    Med Biol; 1984; 62(2):154. PubMed ID: 6471936
    [No Abstract]   [Full Text] [Related]  

  • 38. Biomechanical muscle performance.
    Barr AE; Kroll M
    Muscle Nerve; 1990; 13 Suppl():S21-5. PubMed ID: 2233878
    [No Abstract]   [Full Text] [Related]  

  • 39. Intramuscular renin-angiotensin system is activated in human muscular dystrophy.
    Sun G; Haginoya K; Dai H; Chiba Y; Uematsu M; Hino-Fukuyo N; Onuma A; Iinuma K; Tsuchiya S
    J Neurol Sci; 2009 May; 280(1-2):40-8. PubMed ID: 19232644
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Progressive muscular dystrophies and drug risks].
    Bordet R; Caron J; Destée A; Dupuis B
    Therapie; 1994; 49(2):129-32. PubMed ID: 7817336
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.